Association of serum fibroblast growth factor 19 levels with arteriosclerosis parameters assessed by...
Association of serum fibroblast growth factor 19 levels with arteriosclerosis parameters assessed by arterial stiffness and atherogenic index of plasma in patients with type 2 diabetes
About this item
Full title
Author / Creator
Liu, Wang-shu , Tang, Meng-jie , Xu, Tian-li , Su, Jian-bin , Wang, Xue-qin , Xu, Feng , Zhang, Dong-mei , Zhu, Qing , Cao, Jie and Wang, Hong
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
The role of serum fibroblast growth factor 19 (FGF19) in arteriosclerosis is not well known. In the present study, we aimed to explore whether serum FGF19 levels were related to arteriosclerosis parameters, including arterial stiffness and atherogenic index of plasma (AIP), in patients with type 2 diabetes (T2D).
A total of 200 patients with typ...
Alternative Titles
Full title
Association of serum fibroblast growth factor 19 levels with arteriosclerosis parameters assessed by arterial stiffness and atherogenic index of plasma in patients with type 2 diabetes
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_11f35fb12fe0400f98f23930601756e6
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_11f35fb12fe0400f98f23930601756e6
Other Identifiers
ISSN
1758-5996
E-ISSN
1758-5996
DOI
10.1186/s13098-020-00552-0
